Optimal surgical treatment of locally advanced gynecological malignancies

Zaporozhan, V. M.; Tkachenko, O. I.; Maksymovskyj, V. Y.; Mashukov, A. O.; Pyrogov, V. V.

dc.contributor.author	Zaporozhan, V. M.	en
dc.contributor.author	Tkachenko, O. I.	en
dc.contributor.author	Maksymovskyj, V. Y.	en
dc.contributor.author	Mashukov, A. O.	en
dc.contributor.author	Pyrogov, V. V.	en
dc.date.accessioned	2019-04-02T06:55:31Z
dc.date.available	2019-04-02T06:55:31Z
dc.date.issued	2018
dc.identifier.citation	Optimal surgical treatment of locally advanced gynecological malignancies Zaporozhan V. M., Tkachenko O. I., Maksymovskyj V. Y., Mashukov A. O., Pyrogov V. World science. 2018. Vol. 3, № 1(29). P. 20–22.	en
dc.identifier.issn	2413-1032
dc.identifier.uri	http://repo.odmu.edu.ua:80/xmlui/handle/123456789/4898
dc.description.abstract	The article presents our experience of advanced gynecological malignancies surgical treatment. We retrospectively analyzed 1215 cases of gynecological malignancies and selected 313 patients with locally advanced disease. All patients undergone surgical treatment in University Clinic of Odessa national medical university from 2006 till 2017. 32 HIPEC procedures were included in this study, 24 with cytoreduction. One-year survival was 88,6 % for cervical cancer, 85,2 % for ovarian cancer, 79,1 % for endometrial cancer. Five and ten year survival rate was 31 % and 14 % among ovarian cancer patients, 18 % and 9 % for ovarian cancer, 38 % and 18 % for endometrial cancer respectively. Cytoreduction with HIPEC were well tolerated with no perioperative mortality.	en
dc.language.iso	en	en
dc.subject	gynecological malignancy	en
dc.subject	HIPEC	en
dc.subject	cytoreduction	en
dc.subject	pelvic exenteration	en
dc.subject	urinary diversion	en
dc.title	Optimal surgical treatment of locally advanced gynecological malignancies	en
dc.type	Article	en